Bury, Lancashire, U.K., August 5, 2021 – Kadant U.K. Limited, a subsidiary of Kadant Inc. (NYSE: KAI), announced the appointment of Karl Wilkinson as managing director.

Karl has been with Kadant U.K. for over 16 years supporting the fluid handling and doctoring, cleaning, and filtration product lines. During his tenure with Kadant U.K., he has held various management positions in engineering, commercial/customer care, marketing, and most recently in operations. 

Kevin Callus, vice president, European doctoring operations, commented, “It is with great pleasure and assuredness that we place the future management of Kadant U.K. in the very capable hands of Karl Wilkinson as Managing Director. During his time with Kadant he has implemented quality management systems, stream-lined manufacturing processes, and driven a customer-focused business model with technical services at the center of that methodology.” 

Kadant U.K. Limited, based in Bury, Lancashire, U.K., develops, designs, and manufactures doctor blades, doctor blade holders, and doctoring systems for packaging, tissue, food, and other industrial processes. The companies’ cleaning and filtration products are applied to the cleaning of forming and press fabrics and the filtration of process water. 

About Kadant

Kadant Inc. is a global supplier of high-value, critical components and engineered systems used in process industries worldwide. The Company’s products, technologies, and services play an integral role in enhancing process efficiency, optimizing energy utilization, and maximizing productivity in resource-intensive industries. Kadant is based in Westford, Massachusetts, with approximately 2,800 employees in 21 countries worldwide. For more information, visit www.kadant.com

Safe Harbor Statement

The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements about our customers, products, technologies, and markets. These forward-looking statements represent our expectations as of the date of this press release. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause our actual results to differ materially from these forward-looking statements as a result of various important factors, including those set forth under the heading "Risk Factors" in Kadant’s annual report on Form 10-K for the fiscal year ended January 2, 2021 and subsequent filings with the Securities and Exchange Commission.